Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
FOXO Technologies ( (FOXO) ) has issued an announcement.
On December 15, 2025, FOXO Technologies Inc. announced a year-end review by CEO Seamus Lagan, highlighting significant milestones and strategic acquisitions in 2025. The company expanded its healthcare portfolio by acquiring Myrtle Recovery Centers, Rennova Community Health, and Vector BioSource, enhancing its market position in healthcare and pharmaceutical services. Myrtle Recovery Centers, since its opening in August 2023, has become a leading provider of substance use disorder treatments in Tennessee, while Rennova’s Scott County Community Hospital continues to serve its community with expanded services. The acquisition of Vector BioSource positions FOXO as a growing player in pharmaceutical services, with expectations of substantial revenue growth. Financially, FOXO reported increased revenues and equity, reduced debt, and resolved legacy liabilities, while planning further acquisitions through its newly formed subsidiary, FOXO Acquisition Corporation. Despite losing its NYSE American listing, FOXO aims to relist its common stock in 2026.
Spark’s Take on FOXO Stock
According to Spark, TipRanks’ AI Analyst, FOXO is a Underperform.
FOXO Technologies receives a low overall stock score primarily due to significant financial challenges, including continuous net losses, high debt, and negative cash flows. The technical analysis also suggests bearish momentum. Although valuation metrics are poor, recent corporate actions, such as acquisitions and restructuring, provide some hope for future improvement. However, these are not sufficient to outweigh the current financial and operational challenges facing the company.
To see Spark’s full report on FOXO stock, click here.
More about FOXO Technologies
FOXO Technologies Inc. operates in the healthcare and biotechnology sectors, owning subsidiaries such as Rennova Community Health, Myrtle Recovery Centers, Vector BioSource, and FOXO Labs. The company focuses on healthcare services, biospecimen sourcing, and biotechnology solutions, with a market focus on improving human health and lifespan.
Technical Sentiment Signal: Sell
Current Market Cap: $131.2K
For an in-depth examination of FOXO stock, go to TipRanks’ Overview page.